Literature DB >> 23305612

Changes in insight during treatment for psychotic disorders: a meta-analysis.

Gerdina H M Pijnenborg1, Rozanne J M van Donkersgoed, Anthony S David, André Aleman.   

Abstract

OBJECTIVE: Poor insight, or awareness of illness, has a negative impact on the outcome of the psychosis, and is therefore a logical target for treatment. A meta-analysis of the effect of psychological and pharmacological treatments on insight in psychosis was conducted to give a comprehensive overview of effective interventions.
METHODS: An inclusive literature search (1975-April 2012) was performed in PubMed, ISI Web of Science, and EMBASE. The search terms used were "Insight", "Awareness", "Treatment", "Psychosis", "Therapy" and "Schizophrenia", no language specified. A cross-reference search of eligible articles was performed to identify studies not found in the computerized search. Effect sizes (Cohen's d) of each study and overall were calculated under a random effects model with 95% confidence intervals.
RESULTS: Our literature search resulted in approximately 350 abstracts. Nineteen RCTs that examined treatment effects on insight in patients with psychotic disorders were included. Overall, the interventions had a medium effect (d=.34, 95% CI, 0.12-0.57). The effects of CBT, adherence therapy and psycho-education were small to moderate, but not significant, probably due to a lack of power. There were insufficient data to allow a statistical evaluation of the effect of skills training, medication, video-confrontation and comprehensive intervention programs consisting of multiple components. Few adverse effects on mood were documented but this aspect was seldom quantified.
CONCLUSION: There is a paucity of studies providing data regarding treatment for impaired insight in psychosis. Nevertheless, from the published literature in this meta-analysis, we can confirm that it is a potential therapeutic target and that it is amenable to improvement. Comprehensive intervention programs consisting of multiple components may be particularly promising. Improvements in insight did not seem to be associated with increased depression.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23305612     DOI: 10.1016/j.schres.2012.11.018

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  19 in total

1.  Anosognosia in schizophrenia: hidden in plain sight.

Authors:  Douglas S Lehrer; Jennifer Lorenz
Journal:  Innov Clin Neurosci       Date:  2014-05

Review 2.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

3.  The Role of Insight in Moderating the Association Between Depressive Symptoms in People With Schizophrenia and Stigma Among Their Nearest Relatives: A Pilot Study.

Authors:  Dzmitry Krupchanka; Mikhail Katliar
Journal:  Schizophr Bull       Date:  2016-03-12       Impact factor: 9.306

4.  Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Authors:  Richard J Drake; Merete Nordentoft; Gillian Haddock; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Marion Leboyer; Stefan Leucht; Markus Leweke; Phillip McGuire; Andreas Meyer-Lindenberg; Dan Rujescu; Iris E Sommer; René S Kahn; Shon W Lewis
Journal:  Schizophr Bull       Date:  2015-03-05       Impact factor: 9.306

5.  The "Insight Paradox" in Schizophrenia: Magnitude, Moderators and Mediators of the Association Between Insight and Depression.

Authors:  Martino Belvederi Murri; Mario Amore; Pietro Calcagno; Matteo Respino; Valentina Marozzi; Mattia Masotti; Michele Bugliani; Marco Innamorati; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  Schizophr Bull       Date:  2016-04-11       Impact factor: 9.306

6.  Psychiatric comorbidity among adults with schizophrenia: a latent class analysis.

Authors:  Jack Tsai; Robert A Rosenheck
Journal:  Psychiatry Res       Date:  2013-05-30       Impact factor: 3.222

7.  Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XR.

Authors:  Philip D Harvey; Cynthia O Siu; Antony D Loebel
Journal:  Innov Clin Neurosci       Date:  2017-12-01

8.  Interaction of social role functioning and coping in people with recent-onset attenuated psychotic symptoms: a case study of three Chinese women at clinical high risk for psychosis.

Authors:  TianHong Zhang; HuiJun Li; Kristen A Woodberry; Larry J Seidman; Annabelle Chow; ZePing Xiao; JiJun Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-06       Impact factor: 2.570

9.  Dynamic Interplay Between Insight and Persistent Negative Symptoms in First Episode of Psychosis: A Longitudinal Study.

Authors:  Delphine Raucher-Chéné; Michael Bodnar; Katie M Lavigne; Ashok Malla; Ridha Joober; Martin Lepage
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

10.  Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study.

Authors:  Diego Novick; William Montgomery; Tamas Treuer; Jaume Aguado; Susanne Kraemer; Josep Maria Haro
Journal:  BMC Psychiatry       Date:  2015-08-05       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.